The expression of fibronectin in the repair process after myocardial infarction was studied using two protocols of coronary occlusion in the rabbit: a permanent occlusion or 3 h of occlusion followed by reperfusion (too late for salvage). We found a rapid and progressive increase in cardiac fibronectin expression in the infarcted region of the ventricle. Steady-state mRNA levels for fibronectin increased 13-and 16-fold, respectively, in the permanent and reperfused infarcts 1 d postinfarction. Immunological detection of the protein with a polyclonal antibody against plasma fibronectin showed significant increases of the protein fibronectin in the infarcted myocardium by day 3 in the reperfused group and by day 5 in the permanent coronary occlusion group. Ribonuclease protection assays established the induction of EIIIB containing fibronectin mRNA in both models by day 1 and use of a monoclonal antibody showed an increase in the EIIIA isoform 2 d postinfarction. Increases in steadystate mRNA levels for several collagen types were found in both groups, but these changes occurred after those noted for fibronectin. Thus fibronectin mRNA and protein expression increased rapidly postinfarction suggesting a functional role in the repair process. (J. Clin.
Introduction
An understanding ofthe remodeling process that occurs in the heart after an acute myocardial infarction is important both for the design of appropriate therapeutic interventions and as a relevant model for the study ofthe molecular events associated with wound repair. Changes in the extracellular matrix comprise an important part of the wound repair process, and this topic has been studied extensively, particularly with respect to collagen content and alterations in tensile strength and compliance (1) (2) (3) (4) (5) . Fibronectin is an important component of the extracellular matrix that is thought to have a functional role in diverse cellular processes, including wound healing (6) (7) (8) . Fi- bronectin is a dimeric glycoprotein with a molecular mass of This study was presented in part at the 1990 American Heart Associations Scientific Sessions. 500 kD that is made by most cell types and is present in plasma as well as within the extracellular matrix. It is the product ofa single gene, but is subject to alternative splicing (9) . The circulating form of fibronectin, made primarily by the liver, lacks the protein segments encoded by two exons designated EIIIA and EIIIB (9, 10) . Molecules containing the segments derived from either or both of these exons are made by many nonhepatic cells, and such forms of fibronectin are commonly expressed during the wound healing process.
Much of the published data relating fibronectin to the wound healing process has been obtained using in vitro systems, although recent studies have included in vivo models where immunocytochemical and in situ hybridization techniques were used to show temporal relationships between the alternatively spliced forms of fibronectin made by distinct cell types and the different phases ofwound healing (8) . One major observation was the selective transcription of EIIIA and EIIIB containing mRNAs by proliferating fibroblasts in skin wounds. Both newly synthesized fibronectin and circulating fibronectin accumulate within the wound site and either form could serve as an attractant for infiltrating monocytes or neutrophils, a support for migration of infiltrating fibroblasts, or as a matrix for fibrillar formation of collagen and other extracellular components.
There is very little information available on the role offibronectin in the heart. Ahumada et al. (1 1) examined the cardiac distribution of fibronectin in fetal, neonatal, and adult rat hearts. Using immunocytochemical techniques, an increase in fibronectin within 2 d of aortic banding has been reported in a rat model ofcardiac hypertrophy (12) . Others have also demonstrated the presence offibronectin in healing infarcts by immunocytochemistry (13, 14) . A recent histochemical study documented changes in fibronectin content following an infarct, and found early deposition of fibronectin within myocytes followed by deposition between myocytes at 48 h (15).
In the current study we have used a model of myocardial infarction in the rabbit heart to measure changes in both steady-state mRNA and immunodetectable protein during the
Methods
In this study 91 male New Zealand rabbits, 1.5-2.2 kg, underwent intubation, thoracotomy, and coronary artery ligation as previously described (16) . Anesthesia was obtained with a combination of pentobarbital and lidocaine. The coronary artery was either permanently occluded with a silk suture, or temporarily occluded for 3 h and then reperfused. Coronary occlusion was confirmed by visual inspection for pallor and dyskinesis; reperfusion was verified by visual inspection for hyperemia. This model consistently produces an infarct of 27±2% of the anterior apical region of the left ventricle by weight that is easily identifiable macroscopically at 24 h (17) (18) (19) . The demarcation between infarct and normal tissue is particularly clear on the endocardial surface. In the nonreperfused infarct a marked pallor surrounded by a thin hemorrhagic belt is evident; in the reperfused infarct the infarcted region is hemorrhagic. The central infarct region was dissected from the noninfarcted region by visual inspection as described previously (18, 19) . There were 17 postoperative deaths (7 in the permanent group, 10 in the reperfused group). Four hearts were not used owing to the absence ofan infarct. Rabbits were overdosed with intravenous pentobarbital 1, 2, 3, and 5 d after coronary ligation at exactly 27, 51, 75, and 123 h. For RNA isolation the infarct region was rapidly dissected and frozen in liquid nitrogen. Hearts used for protein analysis were flushed from the aortic cuff with 20 ml of normal saline to remove the blood from the intravascular space, and the infarct region was removed and frozen in liquid nitrogen. Normal hearts were prepared in the same manner for RNA and protein samples.
RNA isolation. RNA was isolated by the method of Chirgwin et al. (20) . RNA samples were separated on 0.9% agarose gels and then transferred to a nylon membrane (Genescreen, New England Nuclear, Boston, MA) by vacuum transfer (Stratavac, Stratagene Inc., La Jolla, CA). Hybridization was performed at 650C overnight using the designated probes labeled by random hexamer priming with [32P]dCTP. The membranes were then washed with 0.8% SSC and 0.2% SDS at 550C for 15 min, followed by 0.5% SSC and 0.5% SDS at 550C for 15 min.
Blots were exposed to preflashed X-Omat film (Eastman Kodak Co., Rochester, MN) at -70'C. Quantitation was carried out by dot blot analysis. 1, 2, and 4 Mg of each RNA sample was applied to a nylon membrane as described previously (21) , and the membranes were processed as described above. To compare all samples within a given experimental group, more than one membrane was required. Each membrane contained 10 samples used as internal controls, and densitometric analysis between blots was normalized using these samples. RNA from normal left ventricles was used as a control on all blots. Densitometry was carried out using an Ultrascan XL (LKB Produkter, Bromma, Sweden).
cDNA. For fibronectin the EcoRI insert from Xrlf-l and prFN-A and prFN-B were used (9) . These plasmids were the generous gift of R. 0. Hynes treated with proteinase K, and phenol extraction was done followed by ethanol precipitation at -70'C. Samples were separated on an 8% sequencing gel. The gel was dried and exposed to x-ray film from overnight to 3 wk depending on the radioactive label used and on the intensity of the signal. After development of the autoradiograph, the bands were aligned with the gel, and the corresponding sections ofthe gel cut out and the radioactivity measured by scintillation counting (LKB Produkter). As comparable results were obtained by direct counting ofthe gel and densitometry, analysis ofthe reported results was done only by laser densitometry (Molecular Dynamics, Sunnyvale, CA). The cDNA probes for EIIIA and EIIIB contain both the alternatively spliced segment and an overlapping segment with plasma fibronectin RNA, which is 109 and 100 bp in length, respectively. Thus RNA containing EIIIA generates a 280-bp (+) fragment in the ribonuclease protection assay, whereas RNA lacking the EIIIA segment generates a 100-bp segment, or "minus" segment (-). For EIIIB the corresponding segments are 350 bp (+) and 109 bp (-). The minus segment provides an internal control for the assay and allows a direct measurement of the relative abundance of the different forms of fibronectin mRNA. The percent of EIIIB (+) fibronectin was calculated by first dividing the densitometry signal for the (+) form by 3.21, then dividing by the sum of the signals for both the (+) and (-) segments, and then multiplying by 100.
Protein analysis. Tissue samples were homogenized in ice-cold 0.1 M phosphate-buffered saline containing protease inhibitors as previously described (26) . The homogenate was then centrifuged at 25,000 g at 4VC for 20 min. The supernatant was removed, and the pellet was resuspended in 4% SDS and heated at 100IC for 5 min. Samples were then centrifuged for 1 min to remove particulate matter, aliquoted, and stored at -70'C. Preliminary Western blot analysis demonstrated that the majority of the fibronectin was located in the SDS fraction. Samples for fibronectin analysis were separated by SDS-PAGE using 8% polyacrylamide, and then transferred to nitrocellulose (Bio-Rad Laboratories, Richmond, CA) at 4VC with 0.5 A for 5 h or 0.1 A for 24 h based on the method of Trotter et al. (27) . Membranes were blocked with 5% milk powder in Tris-buffered saline with 0.05% Tween 20 for 1 h at 370C. Incubation with the first antibody was carried out either for 2 h at room temperature or overnight at 4VC. A polyclonal anti-rabbit plasma fibronectin (The Binding Site, San Diego, CA) was used in a 1:5,000 dilution. After washing with buffer, incubation with an antisheep horseradish peroxidase-linked second antibody (The Binding Site) at 1:5,000 dilution was carried out for 1 h. The membranes were developed using a chemoluminescent system (ECL, Amersham Corp., Arlington Heights, IL) according to the directions ofthe manufacturer. Membranes were exposed to X-Omat film for 30 s to 15 min, depending on signal strength. The results were analyzed using laser densitometry. After development with the ECL system, all Western blots were stained with India ink to confirm the presence of equivalent amounts of protein on the nitrocellulose.
EIIIA Western blotting. Using the same methodology described above, Western blot analysis was performed to examine the amount of fibronectin present containing the EIIIA alternatively spliced segment. A mouse monoclonal antibody to EIIIA was the generous gift of Dr. Luciano Zardi (Cell Biology Laboratory, Instituto Nazionale per la Ricerca sul Cancro, Genoa, Italy, (28, 29). An anti-mouse IgG-horseradish peroxidase (Amersham Corp.) was used in a 1:2000 dilution as the second antibody. Blots were developed as described above. Dot blot analysis. 2, 4, and 10 ug of total protein from individual samples were applied to a nitrocellulose membrane using a dot blot apparatus (Bio-Rad Laboratories). The membrane was washed in Trisbuffered saline with 0.05% Tween 20 and then developed as described above for Western blotting. The anti-fibronectin antibody was used in a 1:5,000 dilution, and the second antibody was used in a 1:4,000 dilution. The same procedure was repeated for analysis usingthe monoclonal antibody to EIIIA. For this antibody, the methods were identical with those described under Western blotting. The blots were then exposed to X-Omat film for 1-5 min. The results were analyzed by using laser densitometry.
Fibronectin Expression in Rabbit Heart after Infarction Statistical analysis. Differences among groups were tested by a one way analysis of variance. The unpaired Student t test was then used to determine significance. A P value of < 0.05 was considered significant. Data is expressed as the mean±SEM unless stated otherwise.
Results Fibronectin. Fig. 1 A summarizes Fig. 4 B. 
REPERFUSED
Changes in total fibronectin could reflect either extravasation from the plasma, or local synthesis in the area of infarct. The alternatively spliced forms offibronectin containing EIIIA or EIIIB are specific for tissue, in that neither the EIIIA nor EIIIB segments are found in plasma fibronectin. The availability of a monoclonal antibody specific for the EIIIA region of fibronectin isoforms made possible an assessment of synthesis offibronectin in the infarct. Dot blot analysis was again used to allow simultaneous comparison ofmultiple samples as summarized in Fig. 5 A. In normal hearts and l-d-old infarcts the EIIIA form was undetectable. In the reperfused infarcts EIIIA was greatly increased compared with normal ventricle at both day 2 and day 3 (P < 0.01). This increase in EIIIA persisted at day 5 compared to normal hearts (P < 0.05), but was less marked. In the permanent infarcts, a similar sharp rise in EIIIA containing fibronectin occurred on the second day (P < 0.05 vs. normal ventricle, P = ns vs. reperfused). However, both the dot blot analysis and Western blot analysis as shown in Fig. 5 B, with confirmation ofequal amounts ofprotein by SDS-PAGE, revealed a marked drop for EIIIA fibronectin at day 3 in the permanent infarcts (P < 0.001 vs. day 3 reperfused). Subsequently, EIIIA levels increased significantly on day 5 postinfarction in the group with permanent coronary occlusion (P < 0.05 vs. normal hearts and vs. day 5 reperfused). These results are summarized in Fig. 5, A and B .
Ribonuclease protection assay. To determine if changes in alternatively spliced forms of fibronectin were selectively in- duced in the ventricles after infarction, ribonuclease protection assays were used to distinguish fibronectin mRNA moieties containing specific exons from those lacking the exon. Representative data are shown in Fig. 6 . Using a probe containing RNA from the EIIIB region ofrat fibronectin, it was possible to quantitate the amount of fully protected RNA in the samples, containing -350 base pairs, relative to the amount lacking that sequence, which corresponded to a protected region of 109 base pairs (Fig. 6) identity between the sequence of rat and rabbit fibronectin mRNA in the EIIIB region and the adjacent region. Attempts were made to quantitate the fibronectin isoforms containing the EIIIA segment, but weaker homology between rat and rabbit EIIIA sequences resulted in several fragments on the gel and quantitation was not possible. Nevertheless, there was a major increase in all fragments by day 1 and this increase persisted throughout the 5-d period of the study (data not shown).
Discussion
Substantial remodeling occurs in the ventricle after myocardial infarction, and this represents a complex model ofwound healing (1, 31). Wound healing has been extensively studied both in vivo and in vitro using other model systems, but little is known of fibronectin's role in the repair processes occurring in the infarcted myocardium. In our study we found a rapid and progressive increase in cardiac fibronectin expression in the necrotic region of the left ventricle after myocardial infarction. Large increases in the steady-state mRNA levels for fibronectin occurred within 27 h of coronary occlusion, and these changes preceded increases in steady-state mRNA for each ofthe three different forms of collagen studied. We found that fibronectin expression increased within 1 d ofinfarction in both permanent and reperfused infarcts. Subtle differences were observed between the reperfused and permanent infarcts, with an earlier increase in total fibronectin occurring in the reperfused infarcts. Synthesis by fibroblasts and extravasation from the plasma are the most likely sources offibronectin in the infarct (11) . Fibronectin is present in normal plasma and in our studies the hearts were vigorously flushed with saline to remove fibronectin present in the intravascular 1064 Knowlton et al. space. The efficacy of this approach was indicated by the very low levels present in normal hearts prepared in this manner. Furthermore, the extraction procedure we employed involved first homogenizing the tissue in phosphate-buffered saline and centrifuging to eliminate any soluble fibronectin not tightly associated with the extracellular matrix. Subsequently, the pellet was extracted with detergent to solubilize fibronectin incorporated in the matrix (32) . Therefore, the changes we observed in fibronectin levels represented matrix-associated protein and were not obscured by contamination with intravascular plasma fibronectin.
Although there was no clear difference in the amount of fibronectin mRNA present in the permanent and reperfused groups, the protein increased earlier in the reperfused infarcts. The methods employed do not distinguish between extravasation and incorporation ofplasma fibronectin vs. earlier synthesis in the infarct as the etiology ofthe increase in total fibronectin. Western blot analysis showed that the amount of EIIIA- containing protein (cellular fibronectin) in the infarct sharply increased at day 2 for both permanent and reperfused infarcts; however, a distinct decrease in the amount of EIIIA containing protein present in the permanent infarcts was observed at day 3 followed by an increase again at day 5. The underlying etiology of the dramatic decline on day 3 in the permanent infarcts is unclear, but the phenomenon was reproducible and found in each of the five animals used. In contrast, the levels of EIIIA containing protein remained elevated in the reperfused infarcts. A ribonuclease protection assay was used to analyze alternative splicing of fibronectin in myocardial infarction. The absolute amount of EIIIB (+) fibronectin mRNA was increased by day 1 postinfarction. These results provide clear evidence ofan increase in the alternatively spliced form offibronectin containing EIIIB within 24 h, earlier than has been previously described in studies using immunocytochemistry (13, 15) . A similar induction of both EIIIA and EIIIB has been found in healing skin wounds by in situ hybridization (8).
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Two immunocytochemical studies have examined the localization of fibronectin in nonreperfused myocardial infarctions in rats (13, 15 deposition owing to extravasation from the plasma and local synthesis in that study because the antibody bound both plasma and cellular fibronectin. In another study of permanent coronary occlusion using a similar antibody, fibronectin deposition was also seen within three hours of infarction (13) . However, in the latter study a monoclonal antibody specific to the ETITA domain of cellular fibronectin also was used and demonstrated the complete absence of cellular fibronectin 3 h after infarction. 3 d after infarction, cellular fibronectin was found, but only in the periphery of the infarct. In the current study we were able to quantitate changes in fibronectin because of the biochemical techniques that were used. Furthermore, we examined the effect of late reperfusion, too late for myocardial salvage, which has potentially important application to the clinical setting.
Although reperfusion is a standard therapy in the management of acute myocardial infarction, studies on the effect of reperfusion on healing have been limited. Late repeffusion produces edema and hemorrhage in the infarcted region (33) (34) (35) , and clinically is associated with increased survival 1 yr postinfarction-Xl, 36, 37), though it may increase the incidence of early postinfarction cardiac rupture (38 (33) . At 1-3 wk postinfarction investigators found no difference in hydroxyproline levels between reperfused and permanent infarcts, (33, 39) . Reperfusion influences early postinfarction remodeling and concurrent changes in infarct composition may influence the final scar formation through alterations in the molecular framework on which collagen is deposited, rather than altering the collagen content (1) .
Infarct expansion and aneurysm formation are major causes of morbidity and mortality postinfarction. Fibronectin has chemotactic properties, binds collagen, and stimulates fibroblast proliferation (40, 41) . Those properties may contribute to the acute phase ofthe repair process postinfarction where cell slippage is thought to contribute to ventricular dilation and infarct expansion, both ofwhich occur within 5-7 d postinfarction before collagen begins to accumulate to form the final scar (1, 2, 37, 424-5). Late reperfusion in animal models of infarction decreases expansion and scar thinning through unknown mechanisms (42, 46, 47) ; the delivery of plasma fibronectin to the infarct through reperfusion, as supported by our data (Fig.  4 A as compared to relative mRNA levels in Fig. 1 ), may be a factor in the observed modulation of the repair process. Previously we have observed thatat 3 d postinfarction the tearthreshold ofinfarcts produced by 3-h coronary occlusion followed by reperfusion was higher than that of infarcts resulting from permanent occlusion (48) . Autopsy data suggested that a myocardial tear is a precipitating factor for rupture postinfarction (49) . In a study of infarct strength, we found that not until day 5 postinfarction did the permanent infarcts achieve a tear threshold comparable to that of reperfused infarcts (48) . Thus the differences observed in fibronectin at the protein level in the current study correlate with the differences observed in tissue strength using the same animal model. This correlation may only be coincidental; however, fibronectin's known binding to collagen and the cell membrane suggests that fibronectin may have a role in this observed difference in tissue strength post-infarction.
There is a paucity of available data on collagen expression in the early stages of cardiac remodeling following infarction. The general process of wound repair is characterized by an early accumulation of fibronectin, and only in the later stages of the process does collagen production increase and replace fibronectin (7, 50) . A similar pattern of change has recently been reported in a rat model of cardiac hypertrophy (12) . In our study the increase in fibronectin mRNA preceded the changes in steady-state mRNA levels for the several different forms of collagen. Our experiments quantitated increases in the mRNA for collagen I, III, and IV. Previous studies measured hydroxyproline and demonstrated no effect of reperfusion on collagen levels at 1 wk and beyond (5, 39 (53, 54) . Histochemical data suggested fibronectin is deposited around myocytes in the early response to infarction (I15). Thus, the temporal differences between induction of fibronectin and collagen in our studies could reflect the action of different cell types, although the possibility cannot be excluded that myocytes, fibroblasts, and vascular tissue make both collagen and fibronectin in a temporal pattern regulated by growth factors in the infarcted region.
Our studies demonstrated that a major increase in fibronectin characterized the early phase of the healing infarct. We are the first to show that one of the tissue-specific, alternatively spliced forms of fibronectin (EIIIB) is dramatically increased 1 d postinfarction. Fibronectin may be important structurally in maintaining the tensile strength of necrotic tissue and preventing infarct expansion, as well as in organizing and regulating the repair process. The acute changes in fibronectin, preceding any increase in collagen, and fibronectin's activity as a potent mediator of cell-cell and cell-substratum interaction support an important role for fibronectin in maintaining the structural integrity of the necrotic myocardium. Although all acute infarcts are necrotic, they rarely rupture, and in fact have a tensile strength similar to normal myocardium despite consisting primarily of dead myocytes (55). Initially we were uncertain whether it would be possible to isolate any RNA from the acute, necrotic infarct. Although less RNA was present in the l-d infarcts compared to normal myocardium, we were able at all time points postinfarction to obtain satisfactory samples.
More work is needed to define the complex series of events that characterize the healing infarct. The remodeling, which occurs in the first few days postinfarction, is a critical determinant of final ventricular size and function. The time course of these structural changes, combined with the time course of fibronectin expression are suggestive of a critical role for fibronectin in preventing expansion and providing the framework for scar formation.
